Avanex (AVXL) shares jumping with 5000 September $20 calls bought $1.20 in a stock replacement and 5000 August $15/$20 call spreads bought for $0.85. AVXL shares with a strong bull flag just under its 200-MA. Berenberg started shares Buy last month with a $40 target noting the market is underestimating the clinical potential of a CNS drug candidate ANAVEX 2-73 may be effective in several therapeutic areas within the CNS space such as Rett Syndrome, Alzheimer’s disease, and Parkinson’s Disease Dementia.